Brio Clinical INC

Brio Clinical INC was paid $13.02M by Medicaid between Jul 2020 and Dec 2024, across 63 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 69% of everything it billed.

Compared with peers

Next to other Mobile Radiology Clinic/Center providers in California

Rank by total paid#1 of 20

Median peer was paid$38K

This provider vs. median342×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	9,391	$573K
2021	49,274	$2.00M
2022	166,347	$7.52M
2023	55,543	$2.33M
2024incomplete	43,955	$607K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	69%	133,184	40,170	$8.92M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	8.9%	10,425	4,100	$1.16M
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	6.8%	42,991	11,545	$890K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	6.6%	50,415	13,998	$866K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	2.2%	2,674	1,531	$288K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.9%	7,411	3,360	$253K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	1.3%	9,803	4,002	$169K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,930	824	$109K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	12,744	8,335	$57K
80053	Comprehensive metabolic panel	<1%	8,096	6,297	$45K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	865	327	$39K
87276		<1%	5,107	1,959	$25K

51 more codes

80048	Basic metabolic panel (calcium, ionized)	<1%	4,525	$24K
87275		<1%	5,102	$24K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,221	$18K
84443	Thyroid stimulating hormone (TSH)	<1%	1,990	$16K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,620	$14K
80061	Lipid panel	<1%	2,058	$13K
87631		<1%	343	$13K
87086	Culture, bacterial; quantitative colony count, urine	<1%	1,942	$7K
36415	Collection of venous blood by venipuncture	<1%	4,358	$7K
82607		<1%	675	$5K
83880		<1%	226	$5K
84134		<1%	508	$5K
87186		<1%	878	$4K
82746		<1%	451	$4K
87077		<1%	888	$4K
87088		<1%	1,039	$3K
80164		<1%	410	$3K
83735		<1%	728	$3K
80202		<1%	279	$3K
87070		<1%	359	$2K
99000		<1%	716	$2K
85027		<1%	657	$2K
80076		<1%	484	$2K
82140		<1%	250	$2K
81003		<1%	1,560	$2K
86769		<1%	50	$1K
81001		<1%	585	$1K
84100		<1%	409	$1K
84153		<1%	153	$1K
84439		<1%	244	$998.73
87205		<1%	263	$841.97
85610		<1%	411	$812.50
82728		<1%	174	$795.42
82274		<1%	71	$793.34
80177		<1%	94	$683.84
83540		<1%	258	$659.97
86480		<1%	13	$659.93
86140		<1%	188	$575.21
85651		<1%	258	$353.31
87324		<1%	65	$340.97
84466		<1%	60	$223.61
87081		<1%	41	$186.51
84436		<1%	71	$164.36
80178		<1%	18	$93.13
80185		<1%	15	$89.43
84550		<1%	57	$86.75
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	18	$77.20
84480		<1%	13	$62.43
87420		<1%	14	$41.74
82043		<1%	27	$30.18
S3601	Emergency stat laboratory charge for patient who is homebound or residing in a nursing facility	<1%	28	$22.05

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSORRENTINO, VINCENZO (CEO)